Your browser doesn't support javascript.
loading
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard, Dale L; Day, Craig W; Bailey, Kevin; Heiner, Matthew; Montgomery, Robert; Lauridsen, Larry; Winslow, Scott; Hoopes, Justin; Li, Joseph K-K; Lee, Jongdae; Carson, Dennis A; Cottam, Howard B; Sidwell, Robert W.
Affiliation
  • Barnard DL; Institute for Antiviral Research, Utah State University, Logan, 84322-5600, USA. honery@usu.edu
Antiviral Res ; 71(1): 53-63, 2006 Aug.
Article in En | MEDLINE | ID: mdl-16621037
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Virus Replication / Severe Acute Respiratory Syndrome / Severe acute respiratory syndrome-related coronavirus / IMP Dehydrogenase Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Antiviral Res Year: 2006 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Virus Replication / Severe Acute Respiratory Syndrome / Severe acute respiratory syndrome-related coronavirus / IMP Dehydrogenase Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Antiviral Res Year: 2006 Document type: Article Affiliation country: Country of publication: